文献速递妇科

程序性细胞死亡蛋白1及其配体表达在子宫内膜癌中的预后意义

Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2018-03-21

本研究为回顾性研究,在183例原发子宫内膜癌样本中定量检测肿瘤中心、浸润边缘和/或肿瘤细胞的免疫细胞中CD8、PD-1和PD-L1的免疫组化表达,并与总生存期和无进展生存期相关分析。结果显示,肿瘤中心高PD-L1表达是全患者和微卫星稳定亚组中无进展生存期的独立不良预后因素,高PD-L1/CD8比值和高PD-L1/PD-1比值亦与更短的无进展生存期独立相关。

要点

  • 肿瘤中心高PD-L1表达是全患者和微卫星稳定亚组中无进展生存期的独立不良预后因素。
  • 高肿瘤中心PD-L1/CD8比值和高PD-L1/PD-1比值与独立更短的无进展生存期相关。
  • 基于肿瘤中心CD8和PD-L1表达将子宫内膜癌分为四组,各组生存期有显著差异。

核心结论

  • 高PD-L1/CD8比值和免疫细胞上高PD-L1表达是子宫内膜癌无进展生存期的独立不良预后因素,为肿瘤微环境提供了见解。

研究设计与样本

  • 回顾性研究,纳入来自单队列的183例原发子宫内膜癌样本,定量检测肿瘤中心、浸润边缘和/或肿瘤细胞的免疫细胞中CD8、PD-1和PD-L1的免疫组化表达,并与总生存期和无进展生存期进行相关性分析。

主要发现

  • 在经临床免疫病理因素调整的重复Cox多变量模型中,高肿瘤中心PD-L1表达是全患者和微卫星稳定亚组中无进展生存期的独立不良预后因素。
  • 免疫标志物比值显示,高肿瘤中心PD-L1/肿瘤中心CD8比值和高肿瘤中心PD-L1/肿瘤中心PD-1比值与独立更短的无进展生存期相关。
  • 基于肿瘤中心CD8和肿瘤中心PD-L1表达将子宫内膜癌分为四组,各组间生存期有显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Monoclonal antibodies targeting programmed cell death-1 (PD-1)/programmed death ligand 1 (PD-L1) demonstrated promising clinical response. The predictive/prognostic value of PD-1/PD-L1 immunohistochemistry (IHC) has been evaluated in many cancer types. However, the prognostic value of PD-1/PD-L1 IHC has not been evaluated in endometrial cancer. METHODS: We conducted a retrospective study to quantify the IHC CD8, PD-1, and PD-L1 expressions in immune cells at center of tumor (CT), invasive margin (IM), and/or tumor cell in 183 primary endometrial cancer samples from a single cohort, followed by their reciprocal combinations, including compartmental differences, and correlated them with overall survival (OS) and progression-free survival (PFS). RESULTS: In repeated Cox multivariable models adjusted by clinicoimmunopathologic factors, high CT-PD-L1 was an independent adverse prognostic factor for PFS in all patients and in the microsatellite-stable subgroup. Immune marker ratios revealed independently shorter PFS for high CT-PD-L1/CT-CD8 and CT-PD-L1/CT-PD-1 ratios. Classification of endometrial cancer into four groups based on CT-CD8 and CT-PD-L1 revealed significantly different survival among groups. CONCLUSIONS: The high PD-L1/CD8 ratio and the high expression of PD-L1 on immune cells were independent poor prognostic factors for PFS in endometrial cancer, providing insights into the tumor microenvironment.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim J, Kim S, Lee HS, et al. Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer. Gynecol Oncol. 2018. PMID: 29572029. doi:10.1016/j.ygyno.2018.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。